XML 161 R145.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT INFORMATION - Revenues by Segment and Product Category (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue from External Customer [Line Items]      
Revenues $ 9,625 $ 8,757 $ 8,124
Selling, general and administrative 3,296 2,917 2,625
Research and development 616 604 529
Operating income 1,546 963 454
Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 9,625 8,757 8,124
Operating income 3,925 3,610 3,434
Pharmaceuticals | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 4,396 3,909 3,642
Devices | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 2,240 1,997 1,872
OTC | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 1,903 1,797 1,619
Branded and Other generics | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 979 960 892
Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 107 94 99
Product sales      
Revenue from External Customer [Line Items]      
Revenues 9,518 8,663 8,025
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 2,729 2,519 2,316
Other revenues      
Revenue from External Customer [Line Items]      
Revenues 107 94 99
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 53 40 48
Salix | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 2,333 2,250 2,090
Selling, general and administrative 458 416 362
Research and development 99 104 50
Operating income 1,602 1,548 1,489
Salix | Pharmaceuticals | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 2,330 2,251 2,090
Salix | Devices | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Salix | OTC | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Salix | Branded and Other generics | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Salix | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 3 (1) 0
Salix | Product sales | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 174 182 189
Salix | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 0 0 0
International | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 1,111 1,071 988
Selling, general and administrative 214 205 181
Research and development 24 23 22
Operating income 376 335 324
International | Pharmaceuticals | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 248 250 258
International | Devices | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
International | OTC | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 173 179 151
International | Branded and Other generics | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 624 588 527
International | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 66 54 52
International | Product sales | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 449 470 421
International | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 48 38 40
Solta Medical | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 440 347 300
Selling, general and administrative 110 88 80
Research and development 18 20 19
Operating income 213 161 135
Solta Medical | Pharmaceuticals | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Solta Medical | Devices | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 440 347 300
Solta Medical | OTC | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Solta Medical | Branded and Other generics | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Solta Medical | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Solta Medical | Product sales | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 98 78 66
Solta Medical | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 1 0 0
Diversified | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 950 943 978
Selling, general and administrative 169 190 211
Research and development 15 18 25
Operating income 626 586 612
Diversified | Pharmaceuticals | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 849 790 826
Diversified | Devices | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 0 0 0
Diversified | OTC | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 6 7 7
Diversified | Branded and Other generics | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 74 120 120
Diversified | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 21 26 25
Diversified | Product sales | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 140 149 130
Diversified | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 0 0 0
Bausch + Lomb | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 4,791 4,146 3,768
Selling, general and administrative 1,690 1,402 1,253
Research and development 121 122 123
Operating income 1,108 980 874
Bausch + Lomb | Pharmaceuticals | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 969 618 468
Bausch + Lomb | Devices | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 1,800 1,650 1,572
Bausch + Lomb | OTC | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 1,724 1,611 1,461
Bausch + Lomb | Branded and Other generics | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 281 252 245
Bausch + Lomb | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Revenues 17 15 22
Bausch + Lomb | Product sales | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 1,868 1,640 1,510
Bausch + Lomb | Other revenues | Operating Segments      
Revenue from External Customer [Line Items]      
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues $ 4 $ 2 $ 8